Turkey falls to 6th among Israel’s export destinations

The US remains the most important destination by far, but the UK has become the largest in Europe.

May 21, 2012 23:26
2 minute read.
Turkey and the European Union

Turkish and European Union flags 311 (R). (photo credit: Wolfgang Rattay / Reuters)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

The pattern of Israeli exports underwent changes in the first quarter of this year, according to an analysis by the economics division of the Israel Export and International Cooperation Institute.

The US remains the most important destination by far, but the UK has become the largest in Europe.

Be the first to know - Join our Facebook page.

Turkey has dropped from third to sixth, as relations between Israel and Turkey continue to be sour. The UK is in second place, up from seventh last year, and is Israel’s largest export destination in Europe.

Total exports of goods (excluding diamonds) to the US were worth $2.4 billion in the first quarter, which represents a sharp 23 percent drop in comparison with the first quarter of 2011. The drop is mainly due to a decline in exports of drugs, with drugs exports being diverted from the US to Europe.

Exports to the UK totaled $650 million, 84% more than in the corresponding quarter.

Exports of drugs to the UK soared 730%.

Holland was the third largest export destination in the first quarter of 2012, down from second in the corresponding quarter last year. Exports to Holland totaled $630m., 18% more than in the corresponding quarter. China was in fourth place, up from fifth. First quarter exports to China totaled $540m., 15% more than in the corresponding quarter.

Germany fell from fourth place in the first quarter of 2011 to fifth in the first quarter of this year. Exports to Germany totaled $410m., down 15%. The Export Institute points out that Germany had been one of Israel’s most stable export destinations, growing consistently from year to year.

Exports to Turkey totaled $390 million in the first quarter this year, down 23% from the corresponding quarter.

According to the Export Institute, chemicals and refined oil products accounted for 65% of exports to Turkey in the first quarter of this year, and a 26% decline in exports in this sector was the main factor in the overall decline.

Export Institute Chairman Ramzi Gabbay said: “The changes in the pattern of Israeli exports reflect the impact of dominant sectors such as drugs, chemicals and electronic components on export figures for markets such as the US, Britain, Holland, Turkey, China and India. Of particular concern is the decline in exports to Germany in most export sectors.

“There is no doubt that Israeli exporters are finding it tough to cope with the difficulties in Israel’s main markets, because of the strength of shekel in real terms in comparison with four-to-five years ago, alongside growing competition from South-East Asian companies,” he added.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection